Abstract
The failure of malignant cells to undergo apoptosis is a major obstacle in cancer therapy, and thus identifying the underlining molecules involved therein is imperative for improving patient survival. An important mechanism of drug resistance is cell adhesion-mediated drug resistance (CAM-DR). In this study we identify a novel switch by which glioblastoma multiforme (GBM) cells alter the mode of CAM-DR. In the absence of a microenvironmental cue provided by components of the extracellular matrix (ECM), GBM cells are able to employ an alternative, but equally effective, mode of CAM-DR by forming spheres via cell–cell interactions. Intriguingly, when inhibiting cell–cell interactions in the absence of ECM components, either by low cell density or by inhibition of gap junctions (intercellular connexin tunnels) through chemical inhibition with carbenoxyolone or co-incubation with the connexin-mimicking Gap 27 Cx37,43 peptide, GBM cells were sensitized to tumor necrosis factor-related apoptosis-inducing ligand- and CD95-induced apoptosis. By demonstrating that GBM cells can alternate from one form of CAM-DR (cell-substrate tethering) to another (homocellular cell–cell adhesion) and that inhibition of both forms is necessary for apoptosis sensitization, our findings not only have important implications for novel approaches to restore defective apoptosis programs, but also reveal a novel role of gap junctions in GBM.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bellail AC, Hunter SB, Brat DJ, Tan C, Van Meir EG . (2004). Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int J Biochem Cell Biol 36: 1046–1069.
Belot N, Rorive S, Doyen I, Lefranc F, Bruyneel E, Dedecker R et al. (2001). Molecular characterization of cell substratum attachments in human glial tumors relates to prognostic features. Glia 36: 375–390.
Bissell MJ, Radisky D . (2001). Putting tumours in context. Nat Rev Cancer 1: 46–54.
Calaora V, Rogister B, Bismuth K, Murray K, Brandt H, Leprince P et al. (2001). Neuregulin signaling regulates neural precursor growth and the generation of oligodendrocytes in vitro. J Neurosci 21: 4740–4751.
Cheng A, Tang H, Cai J, Zhu M, Zhang X, Rao M et al. (2004). Gap junctional communication is required to maintain mouse cortical neural progenitor cells in a proliferative state. Dev Biol 272: 203–216.
Cordes N, Meineke V . (2003). Cell adhesion-mediated radioresistance (CAM-RR). Extracellular matrix-dependent improvement of cell survival in human tumor and normal cells in vitro. Strahlenther Onkol 179: 337–344.
Dalton WS . (1999). The tumor microenvironment as a determinant of drug response and resistance. 2: 285–288.
Davidson JS, Baumgarten IM, Harley EH . (1986). Reversible inhibition of intercellular junctional communication by glycyrrhetinic acid. Biochem Biophys Res Commun 134: 29–36.
Durand RE, Sutherland RM . (1972). Effects of intercellular contact on repair of radiation damage. Exp Cell Res 71: 75–80.
Elliott T, Sethi T . (2002). Integrins and extracellular matrix: a novel mechanism of multidrug resistance. Expert Rev Anticancer Ther 2: 449–459.
Frame MC . (2004). Newest findings on the oldest oncogene; how activated src does it. J Cell Sci 117: 989–998.
Fulda S, Sieverts H, Friesen C, Herr I, Debatin KM . (1997). The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res 57: 3823–3829.
Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S et al. (2004). Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64: 7011–7021.
Gladson CL, Wilcox JN, Sanders L, Gillespie GY, Cheresh DA . (1995). Cerebral microenvironment influences expression of the vitronectin gene in astrocytic tumors. J Cell Sci 108 (Pt 3): 947–956.
Goldberg GS, Moreno AP, Bechberger JF, Hearn SS, Shivers RR, MacPhee DJ et al. (1996). Evidence that disruption of connexon particle arrangements in gap junction plaques is associated with inhibition of gap junctional communication by a glycyrrhetinic acid derivative. Exp Cell Res 222: 48–53.
Green LM, Bianski BM, Murray DK, Rightnar SS, Nelson GA . (2005). Characterization of accelerated iron-ion-induced damage in gap junction-competent and -incompetent thyroid follicular cells. Radiat Res 163: 172–182.
Gurney JG, Kadan-Lottick N . (2001). Brain and other central nervous system tumors: rates, trends, and epidemiology. Curr Opin Oncol 13: 160–166.
Hazlehurst LA, Dalton WS . (2001). Mechanisms associated with cell adhesion mediated drug resistance (CAM-DR) in hematopoietic malignancies. Cancer Metastasis Rev 20: 43–50.
Hazlehurst LA, Enkemann SA, Beam CA, Argilagos RF, Painter J, Shain KH et al. (2003b). Genotypic and phenotypic comparisons of de novo and acquired melphalan resistance in an isogenic multiple myeloma cell line model. Cancer Res 63: 7900–7906.
Hazlehurst LA, Landowski TH, Dalton WS . (2003a). Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death. Oncogene 22: 7396–7402.
Huang RP, Fan Y, Hossain MZ, Peng A, Zeng ZL, Boynton AL . (1998). Reversion of the neoplastic phenotype of human glioblastoma cells by connexin 43 (cx43). Cancer Res 58: 5089–5096.
Knight MJ, Riffkin CD, Muscat AM, Ashley DM, Hawkins CJ . (2001). Analysis of FasL and TRAIL induced apoptosis pathways in glioma cells. Oncogene 20: 5789–5798.
Krysko DV, Leybaert L, Vandenabeele P, D′Herde K . (2005). Gap junctions and the propagation of cell survival and cell death signals. Apoptosis 10: 459–469.
Labarca C, Paigen K . (1980). A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 102: 344–352.
Levin VA . (1999). Chemotherapy for brain tumors of astrocytic and oligodendroglial lineage: the past decade and where we are heading. Neuro Oncol 1: 69–80.
Morin PJ . (2003). Drug resistance and the microenvironment: nature and nurture. Drug Resist Updat 6: 169–172.
Oliveira R, Christov C, Guillamo JS, Debouard S, Palfi S, Venance L et al. (2005). Contribution of gap junctional communication between tumor cells and astroglia to the invasion of the brain parenchyma by human glioblastomas. BMC Cell Biol 6: 7.
Oloumi A, MacPhail SH, Johnston PJ, Banath JP, Olive PL . (2000). Changes in subcellular distribution of topoisomerase IIalpha correlate with etoposide resistance in multicell spheroids and xenograft tumors. Cancer Res 60: 5747–5753.
Sanai N, Alvarez-Buylla A, Berger MS . (2005). Neural stem cells and the origin of gliomas. N Engl J Med 353: 811–822.
Schmid-Kotsas A, Gross HJ, Menke A, Weidenbach H, Adler G, Siech M et al. (1999). Lipopolysaccharide-activated macrophages stimulate the synthesis of collagen type I and C-fibronectin in cultured pancreatic stellate cells. Am J Pathol 155: 1749–1758.
Schmidmaier R, Baumann P, Simsek M, Dayyani F, Emmerich B, Meinhardt G . (2004). The HMG-CoA reductase inhibitor simvastatin overcomes cell adhesion-mediated drug resistance in multiple myeloma by geranylgeranylation of Rho protein and activation of Rho kinase. Blood 104: 1825–1832.
Shain KH, Dalton WS . (2001). Cell adhesion is a key determinant in de novo multidrug resistance (MDR): new targets for the prevention of acquired MDR. Mol Cancer Ther 1: 69–78.
Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T et al. (2004). Identification of human brain tumour initiating cells. Nature 432: 396–401.
Soroceanu L, Manning TJ, Sontheimer H . (2001). Reduced expression of connexin-43 and functional gap junction coupling in human gliomas. Glia 33: 107–117.
Sutherland RM, Durand RE . (1972). Cell contact as a possible contribution to radiation resistance of some tumours. Br J Radiol 45: 788–789.
Trauth BC, Klas C, Peters AM, Matzku S, Moller P, Falk W et al. (1989). Monoclonal anyibody-mediated tumor regression by induction of apoptosis. Science 245: 301–305.
Uhm JH, Dooley NP, Kyritsis AP, Rao JS, Gladson CL . (1999). Vitronectin, a glioma-derived extracellular matrix protein, protects tumor cells from apoptotic death. Clin Cancer Res 5: 1587–1594.
Wei CJ, Francis R, Xu X, Lo CW . (2005). Connexin43 associated with an N-cadherin-containing multiprotein complex is required for gap junction formation in NIH3T3 cells. J Biol Chem 280: 19925–19936.
Westhoff MA, Serrels B, Fincham VJ, Frame MC, Carragher NO . (2004). SRC-mediated phosphorylation of focal adhesion kinase couples actin and adhesion dynamics to survival signaling. Mol Cell Biol 24: 8113–8133.
Yuan X, Curtin J, Xiong Y, Liu G, Waschsmann-Hogiu S, Farkas DL et al. (2004). Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 23: 9392–9400.
Zhang W, Couldwell WT, Simard MF, Song H, Lin JH-C, Nedergaard M . (1999). Direct gap junction communication between malignant glioma cells and astrocytes. Cancer Res 59: 1994–2003.
Acknowledgements
We thank M Adam-Jäger and S Piater for expert technical assistance. This work has been partially supported by grants from the Deutsche Forschungsgemeinschaft, the Deutsche Krebshilfe, the Ministry of Science, Research and Arts of Baden-Württemberg, IZKF Ulm, Wilhelm-Sander-Stiftung and Else-Kröner-Fresenius-Stiftung (to SF and KMD).
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc).
Rights and permissions
About this article
Cite this article
Westhoff, M., Zhou, S., Bachem, M. et al. Identification of a novel switch in the dominant forms of cell adhesion-mediated drug resistance in glioblastoma cells. Oncogene 27, 5169–5181 (2008). https://doi.org/10.1038/onc.2008.148
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2008.148
Keywords
This article is cited by
-
The limitations of targeting MEK signalling in Glioblastoma therapy
Scientific Reports (2020)
-
Blocking distinct interactions between Glioblastoma cells and their tissue microenvironment: A novel multi-targeted therapeutic approach
Scientific Reports (2018)
-
Fact or fiction - identifying the elusive multiple myeloma stem cell
Journal of Hematology & Oncology (2013)
-
Systematically characterizing and prioritizing chemosensitivity related gene based on Gene Ontology and protein interaction network
BMC Medical Genomics (2012)
-
Influence of stress on extracellular matrix and integrin biology
Oncogene (2011)